STAY UP TO DATE

SciLifeLab / News / Self-sampling could double the detection rate of women with risk for cervical cancer

Self-sampling could double the detection rate of women with risk for cervical cancer

Using self-sampling followed by HPV-test, twice as many women with cervical intraepithelial neoplasia-positive (CIN2+) could be identified compared to Pap smear cytology. This is the conclusion from a study led by Ulf Gyllensten, Uppsala University/SciLifeLab, published in British Journal of Cancer.

Read full press release by Uppsala University (in Swedish)

Read full scientific paper

STAY UP TO DATE

Last updated: 2018-02-14

Content Responsible: Scilifelab Administration()

Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.
Take the survey
Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.
Take the survey